Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
129,287,238
-
Share change
-
+2,388,383
-
Total reported value
-
$16,238,624,437
-
Put/Call ratio
-
91%
-
Price per share
-
$125.59
-
Number of holders
-
856
-
Value change
-
+$284,309,500
-
Number of buys
-
419
-
Number of sells
-
358
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q2 2025
As of 30 Jun 2025,
BIOGEN INC. - COM (BIIB) was held by
856 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
129,287,238 shares.
The largest 10 holders included
VANGUARD GROUP INC, PRIMECAP MANAGEMENT CO/CA/, BlackRock, Inc., STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, GEODE CAPITAL MANAGEMENT, LLC, Point72 Asset Management, L.P., Invesco Ltd., NORGES BANK, and MORGAN STANLEY.
This page lists
858
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.